Form 4 for BCPC BALCHEM CORP
Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-08 · accession 0001140361-24-007121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-12 | 2024-02-08 | BCPC | Harris Theodore L | COB, Pres, CEO, Dir | A - Grant | $0.00 | +27.3K | 111.3K | +32% | $0 |
| D | 2024-02-12 | 2024-02-08 | BCPC | Harris Theodore L | COB, Pres, CEO, Dir | F - Tax | $143.43 | -11.8K | 99.5K | -11% | -$1.69M |
| D | 2024-02-12 | 2024-02-08 | BCPC | Harris Theodore L | COB, Pres, CEO, Dir | A - Grant | $0.00 | +21.5K | 21.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-08 | A | A | 6,650 | $0.00 | 90,672 | D | — | — | (F1) Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. (F2) Includes acquisition of shares under the Balchem Corporation 401(k) plan. |
| 2 | Common | Common Stock | 2024-02-08 | A | A | 20,639 | $0.00 | 111,311 | D | — | — | (F3) Represents the vesting of performance stock units (includes 316 dividend equivalent shares) for the 2021-2023 performance period. |
| 3 | Common | Common Stock | 2024-02-08 | F | D | 11,768 | $143.43 | 99,543 | D | — | — | (F4) 11,768 of the 20,639 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. |
| 4 | Derivative | Stock Option | 2024-02-08 | A | A | 21,500 | $0.00 | 21,500 | D | $143.43 · — to 2034-02-08 | 21,500 Common Stock | (F5) Options vest 20% Year 1; 40% Year 2: and 40% Year 3. |